Searched for
ANIMAL HEALTHCARE BUSINESS
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIt is probably time to be bullish as an investor. But remember two things. One: Valuations are still not cheap. Two: Because it is over and...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe latest escalation in the US-Iran war means that crude oil price is back as a risk for India. Although we are in a market already strugg...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Fredun Pharmaceuticals board approves 2:1 bonus issueFredun Pharmaceuticals’ board has recommended a 2:1 bonus issue, granting two new equity shares for every one held. This decision aims to r...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the latest news flow from the Gulf region, the probability is high that we might once again see the bulls attempting a comeback. As u...
- Specialty chemicals: Is China still the same threat, or is this a contrarian moment? 7 stocks to be brought back on the watchlistWhen it comes to the Indian speciality chemicals sector, China and its dumping matters. But there have been subtle but significant changes ...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsAs far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- India–New Zealand sign 'once-in-a-generation' FTAIndia and New Zealand signed a “once-in-a-generation” free trade agreement on Monday that gives New Delhi duty-free access to 100% of tarif...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- Sanofi, Boehringer Ingelheim seek CCI nod for $25-billion global asset swap dealThe commission will review if the two companies swapping their businesses will cause any adverse impact on the local competition.
- Global drug cos set sights on India’s veterinary marketAnimal healthcare in India is no longer an afterthought, as global pharmaceutical companies facing loss in revenues due to expiring drug pa...
- Pfizer to acquire RFCL’s animal healthcare unit for Rs 375 crPfizer is all set to acquire RFCL’s animal healthcare division from ICICI Venture in a deal estimated to be at $75 million (approximately R...
- Wockhardt eyes Rs 150 cr from vet unit saleWockhardt will sell its animal healthcare business for an amount not less than Rs 150 crore. The company on Wednesday proposed the divestme...
- Pfizer may buy RFCL's veterinary co for Rs 250 crPfizer has emerged as the frontrunner to acquire RFCL's animal health unit, Vetnex, in a deal estimated around Rs 250 crore.
- MNCs start due diligence to buy Wockhardt health bizMultinational pharma firms are currently doing a due diligence of Wockhardt's animal healthcare business that has been put on block, accord...
- MNC pharma cos in race for RFCL unitVirbac, Sanofi Aventis and Pfizer have evinced interest in buying animal healthcare unit of RFCL, the fine-chemical business owned by ICICI...
- Cadila to complete buyout of Sarabhai joint ventureZydus group’s Cadila Healthcare has entered into a share purchase agreement with Ambalal Sarabhai Enterprises to acquire the remaining 50% ...
Load More
